Moderna Charging Much More for COVID-19 Vaccine Than Others
FRIDAY, Aug. 7, 2020 -- Moderna is charging $37 a dose for its experimental vaccine, which is far more than what other companies say they plan to charge for their vaccines, CBS News reported Wednesday. Because two doses of the vaccine are needed to immunize people from COVID-19, total costs could be $74 per person.
Moderna's vaccine is currently in phase 3 trials, and the company is confident that the vaccine -- its first commercial product -- will be available by the end of the year.
Last week, Sanofi and GlaxoSmithKline signed a deal with the U.S. government to produce 100 million doses of a vaccine for about $10.50 each, according to calculations from analyst Mani Foroohar, M.D., of the brokerage firm SVB Leerink. Meanwhile, Pfizer has said it will price its vaccine at $19.50 per dose. In a conference call with analysts, Moderna executives said they have been charging between $32 and $37 for doses of the company's vaccine. That is nearly 90 percent more than Pfizer is charging and triple the cost of the Sanofi-GSK vaccine, CBS News reported.
"We are working with governments around the world, and ours, to ensure the vaccine is accessible regardless of our ability to pay," Moderna CEO Stéphane Bancel said during the call, CBS News reported. "And we will be responsible on price, well below value, during the pandemic."
© 2021 HealthDay. All rights reserved.
Posted August 2020
Further Support and Information on COVID-19
Read this next
TUESDAY, July 27, 2021 -- COVID-19 cases in Britain have fallen for six days in a row, even though the government lifted all but a few social-distancing restrictions last...
TUESDAY, July 27, 2021 -- Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation...
TUESDAY, July 27, 2021 -- In a sign that the United States has reached a "tipping point" in its campaign to vaccinate Americans, California and New York City announced vaccine or...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.